JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Search

Smith & Nephew PLC ADR

Затворен

31.18 0.94

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

31.11

Максимум

31.27

Ключови измерители

By Trading Economics

Приходи

35M

331M

Продажби

203M

3.2B

P/E

Средно за сектора

22.441

67.147

Дивидентна доходност

2.44

Марж на печалбата

10.368

Служители

16,988

EBITDA

133M

856M

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+2.7% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

2.44%

2.36%

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-1.5B

14B

Предишно отваряне

30.24

Предишно затваряне

31.18

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

Smith & Nephew PLC ADR Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

3.05.2026 г., 23:47 ч. UTC

Печалби

National Australia Bank Warns of Economic Shock as 1st Half Profit Falls -- Update

3.05.2026 г., 22:35 ч. UTC

Печалби

National Australia Bank Holds Dividend Despite 19% 1st Half Profit Drop

3.05.2026 г., 23:39 ч. UTC

Пазарно говорене

Gold Edge Higher Amid Signs of Resilience -- Market Talk

3.05.2026 г., 23:34 ч. UTC

Пазарно говорене

Oil Declines Amid Mild Risk-on Sentiment -- Market Talk

3.05.2026 г., 23:32 ч. UTC

Печалби

National Australia Bank Warns of Economic Shock as 1H Profit Falls -- Update

3.05.2026 г., 23:30 ч. UTC

Пазарно говорене

Nickel Industries Result Shows Power of Higher Prices -- Market Talk

3.05.2026 г., 23:20 ч. UTC

Пазарно говорене

RBA Likely to Hike Rates; Guidance and Board Split Key -- Market Talk

3.05.2026 г., 23:16 ч. UTC

Придобивния, сливания и поглъщания

GameStop Is Offering to Buy eBay for $56 Billion, CEO Ryan Cohen Says -- WSJ

3.05.2026 г., 22:57 ч. UTC

Придобивния, сливания и поглъщания

GameStop Is Offering to Buy eBay For $56 Billion, CEO Ryan Cohen Says -- WSJ

3.05.2026 г., 22:57 ч. UTC

Придобивния, сливания и поглъщания

GameStop Has Roughly 5% Stake in eBay, Cohen Says -- WSJ

3.05.2026 г., 22:57 ч. UTC

Придобивния, сливания и поглъщания

GameStop Offering to Buy eBay for $125 a Share, or About $56 Billion, CEO Ryan Cohen Says -- WSJ

3.05.2026 г., 22:57 ч. UTC

Придобивния, сливания и поглъщания

GameStop Is Prepared to Run Proxy Fight If eBay Isn't Receptive to a Deal, Cohen Says -- WSJ

3.05.2026 г., 22:57 ч. UTC

Придобивния, сливания и поглъщания

GameStop Has Around $20 Billion in Debt Financing Committed From TD Bank, Cohen Says -- WSJ

3.05.2026 г., 22:45 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

3.05.2026 г., 22:45 ч. UTC

Пазарно говорене

Low-Cost Miners in Spotlight Amid High Energy Prices -- Market Talk

3.05.2026 г., 22:20 ч. UTC

Печалби

National Australia Bank Holds Dividend Despite 19% 1H Profit Drop

3.05.2026 г., 22:08 ч. UTC

Печалби

NAB's 1H Included Previously Announced A$1.35B Software Amortization Charge>NAB.AU

3.05.2026 г., 22:05 ч. UTC

Печалби

NAB 1H Net Interest Income A$9.16B Vs. A$8.445B>NAB.AU

3.05.2026 г., 22:05 ч. UTC

Печалби

NAB 1H Credit Impairment Charge A$706M Vs. A$348M>NAB.AU

3.05.2026 г., 22:05 ч. UTC

Печалби

NAB 1H Operating Expenses A$5.02B Vs. A$4.81B>NAB.AU

3.05.2026 г., 22:04 ч. UTC

Печалби

NAB 1H Net Interest Margin 1.81%>NAB.AU>NAB.AU

3.05.2026 г., 22:03 ч. UTC

Печалби

NAB 1H Cash Return on Equity Ex-Large Notable Items 11.6%>NAB.AU

3.05.2026 г., 22:03 ч. UTC

Печалби

NAB 1H Cash Return on Equity 8.5%>NAB.AU

3.05.2026 г., 22:02 ч. UTC

Печалби

NAB 1H CET1 Capital Ratio 11.65% Vs. 12.01%>NAB.AU

3.05.2026 г., 22:02 ч. UTC

Печалби

NAB 1H Cash Earnings A$2.64B>NAB.AU

3.05.2026 г., 22:02 ч. UTC

Печалби

NAB 1H Cash Earnings Ex-Notable Items A$3.59B Vs. A$3.58B>NAB.AU

3.05.2026 г., 22:01 ч. UTC

Печалби

National Australia Bank Keeps Dividend at A$0.85 >NAB.AU

3.05.2026 г., 22:01 ч. UTC

Печалби

National Australia Bank 1H Rev A$11.16B Vs. A$10.28B >NAB.AU

3.05.2026 г., 22:01 ч. UTC

Печалби

National Australia Bank 1H Net A$2.75B Vs. Net A$3.41B >NAB.AU

3.05.2026 г., 15:06 ч. UTC

Печалби

Berkshire's Greg Abel Marks His First Annual Meeting as CEO. We'd Give Him a B-Plus. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Smith & Nephew PLC ADR Прогноза

Ценова цел

By TipRanks

2.7% нагоре

12-месечна прогноза

Среден 32 USD  2.7%

Висок 32 USD

Нисък 32 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за Smith & Nephew PLC ADR през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

1 ratings

0

Купи

1

Задържане

0

Продай

Техническа оценка

By Trading Central

26.64 / 28.37Подкрепа & съпротива

Краткосрочен план

Bullish Evidence

Средносрочен план

Bullish Evidence

Дългосрочен план

Bullish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat